5 amino 1mq subq protocol 5-Amino-1MQ Research Compound | >99% Purity clinical

5 amino 1mq subq protocol 5-Amino-1MQ Research Compound | >99% Purity clinical

Nicotinamide N-Methyltransferase (NNMT) and Liver Cancer: From Metabolic Networks to Therapeutic Targets

METALLURGY C07—ORGANIC CHEMISTRY C07D—HETEROCYCLIC COMPOUNDS C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom C07D215/04—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms C07D215/10—Quaternary compounds C—CHEMISTRY

clinical

Size:15mL

Originally developed by Metabolic Pharmaceuticals in Australia, scientific investigations have identified AOD9604 as one of the most significant selective lipolytic compounds within growth-hormone fragment research because of its ability to isolate the fat-metabolism activity of hGH without producing the IGF-1 stimulation, insulin resistance or proliferative endocrine effects associated with full-length HGH 191AA